VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RDGT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RDGTRidgetech Inc.
$1.33$346
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRDGTBalance Sheet

Ridgetech Inc. (RDGT) Balance Sheet

18Y historyFree accessUpdated daily

The company has aggressively deleveraged, reducing total debt from a peak of $52.2M in 2022Q2 to $4.7M in 2026Q2, while retained earnings remain deeply negative at -$63.4M.

RDGT Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMMar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Jul'08Jul'07
Total Current Assets56.74M59.71M69.68M64.48M75.36M72.23M60.99M56.2M62.32M55.96M46.88M42.29M27.73M45.16M47.85M39.46M15.01M1.61K30.35K
Cash & Short-Term Investments13.94M12.78M20.15M18.81M18.46M22.14M16.33M9.5M15.31M18.45M7.14M5.33M4.45M4.52M3.83M6.49M801.59K1.61K30.35K
Cash Only13.94M12.78M20.15M18.81M18.46M22.05M16.18M9.32M15.13M18.36M6.67M4.02M4.45M4.52M3.83M6.49M801.59K1.61K30.35K
Short-Term Investments0000091.47K157.16K180.93K175.14K87.07K465.17K1.31M0000000
Accounts Receivable26.45M30.23M19.08M16.84M22.5M18.52M14.9M13.31M11.7M11.08M9.45M10.51M6.88M13.14M17.12M2.53M1.51M00
Days Sales Outstanding33.6591.9845.0541.3249.9650.7646.3445.1644.4349.6438.7149.8737.9853.5866.2313.229.99--
Inventory10.51M9.76M16.25M15.31M16.02M16.97M12.25M13.96M13.43M9.92M10.8M10.54M7.05M8.59M6.88M4.62M3.77M00
Days Inventory Outstanding21.6730.6748.0548.7945.7359.6348.6961.7864.5155.8355.159.6842.5741.8737.5734.5235.95--
Other Current Assets5.84M6.51M12.78M12.85M16.96M12.75M14.97M15.51M16.32M9.43M13.75M8.99M3.13M2.41M3.22M1.47M2.08M00
Total Non-Current Assets4.65M4.78M25.37M26.49M31.03M34.08M38.53M16.53M11.49M11.21M15.19M17.22M18.18M22.68M27.11M14.48M9.01M00
Property, Plant & Equipment7.09K8.93K18.73M19.03M19.66M23.33M29.35M8.73M4.08M5.44M8.14M9.79M12.29M18.71M21.18M5.47M1.19M00
Fixed Asset Turnover29.42x13433.17x8.25x7.82x8.36x5.71x4.00x12.32x23.56x14.98x10.94x7.85x5.38x4.78x4.45x12.79x46.51x--
Goodwill1.46M1.46M00000000023.62K001.47M0000
Intangible Assets3.18M3.3M3.65M3.89M4.37M4.38M4.44M4.79M4.06M2.71M2.93M3.12M1.57M1.2M1.35M6.47M000
Long-Term Investments2.43M01.2M1.77M4.51M3.98M2.54M24.24K40.89K46.15K108.54K00000000
Other Non-Current Assets001.8M1.8M2.48M2.38M2.2M2.98M3.32M3.01M4.01M4.29M4.32M2.77M3.12M2.54M7.82M00
Total Assets61.39M64.48M95.06M90.97M106.38M106.31M99.52M72.73M73.81M67.17M62.07M59.51M45.91M67.84M74.96M53.93M24.02M1.61K30.35K
Asset Turnover3.28x1.86x1.63x1.64x1.55x1.25x1.18x1.48x1.30x1.21x1.43x1.29x1.44x1.32x1.26x1.30x2.30x--
Asset Growth %-63.11%-32.16%4.49%-14.49%0.07%6.83%36.83%-1.47%9.88%8.22%4.31%29.62%-32.33%-9.5%38.98%124.56%1495379.27%-94.71%-
Total Current Liabilities31.12M34.36M74.36M66.54M74.45M64.9M57.44M55.21M54.81M40.01M42.12M41.96M31.27M29.67M22.58M11.72M7.33M00
Accounts Payable21.85M19.67M31.63M26.99M27.33M29.9M21.56M23.11M25.26M19.44M16.67M15.92M14.55M13.78M13.91M3.53M2.33M00
Days Payables Outstanding41.3661.8193.5386.0278.01105.0385.72102.3121.33109.3985.0290.1387.9267.197626.3922.22--
Short-Term Debt4.66M10.39M31.95M29.26M36.15M28.98M30.3M25.95M19.18M12.69M17.63M15.79M8.28M7.19M4.21M2.7M2.34M00
Deferred Revenue (Current)1.26M264.07K518.24K695.93K1.87M1.15M708.14K771.94K4.04M2.68M2.61M3.76M3.19M4.83M1.33M2.04M000
Other Current Liabilities4.61M000000000000000000
Current Ratio1.82x1.74x0.94x0.97x1.01x1.11x1.06x1.02x1.14x1.40x1.11x1.01x0.89x1.52x2.12x3.37x2.05x--
Quick Ratio1.49x1.45x0.72x0.74x0.80x0.85x0.85x0.77x0.89x1.15x0.86x0.76x0.66x1.23x1.81x2.97x1.53x--
Cash Conversion Cycle13.9660.83-0.434.0917.675.369.324.65-12.39-3.918.819.42-7.3628.2627.8121.3523.72--
Total Non-Current Liabilities484.78K492.12K6.4M7.77M9.2M17.01M23.3M547.18K138.8K496.22K636.3K315.33K278.92K15.61K34.42K153.23K000
Long-Term Debt000001.89M4.12M000000000000
Capital Lease Obligations12.94M06.4M7.77M9.2M15.12M19.05M000000000000
Deferred Tax Liabilities492.12K492.12K00000000000000000
Other Non-Current Liabilities484.78K00000134.6K547.18K138.8K496.22K636.3K315.33K278.92K15.61K34.42K153.23K000
Total Liabilities31.61M34.85M80.76M74.3M83.65M81.91M80.74M55.76M54.95M40.51M42.76M42.28M31.54M29.69M22.61M11.87M7.33M00
Total Debt4.66M10.39M43.22M42.16M48.67M46.78M54.45M25.95M19.18M12.69M17.63M15.79M8.28M7.19M4.21M2.7M2.34M00
Net Debt-9.27M-2.39M23.07M23.35M30.22M24.74M38.27M16.63M4.05M-5.67M10.95M11.76M3.83M2.66M375.71K-3.79M1.54M-1.61K-30.35K
Debt / Equity0.16x0.35x3.02x2.53x2.14x1.92x2.90x1.53x1.02x0.48x0.91x0.92x0.58x0.19x0.08x0.06x0.14x--
Debt / EBITDA2.67x2.09x23.36x----32.43x--12.32x3.49x--0.33x-0.18x--
Net Debt / EBITDA-5.31x-0.48x12.47x----20.78x--7.65x2.60x--0.03x-0.12x--
Interest Coverage---305.63x-314.00x-7.00x-17.33x-8.22x---4120.44x4.50x----485.08x196.38x--
Total Equity29.78M29.64M14.29M16.67M22.74M24.4M18.78M16.97M18.86M26.66M19.32M17.23M14.36M38.15M52.35M42.06M16.69M1.61K30.35K
Equity Growth %155.83%107.35%-14.24%-26.7%-6.82%29.95%10.65%-10.03%-29.26%38.04%12.08%19.98%-62.35%-27.13%24.46%152.03%1039112.27%-94.71%-
Book Value per Share114536.90120473.10223330.27724658.78999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00--
Total Shareholders' Equity29.78M29.64M15.64M18.01M24.09M25.74M20.59M18.17M18.86M26.66M19.32M17.19M14.32M38.15M52.35M42.06M16.69M1.61K30.35K
Common Stock5.86K1.41M418.41K284.37K41.75K41.75K32.94K28.94K28.94K25.21K17.74K15.65K14.42K13.61K13.59K13.53K10K4.2K4.2K
Retained Earnings-63.37M-63.31M-73.51M-69.27M-48.13M-44.94M-36.4M-30.59M-29.66M-12.6M-6.96M-7.4M-8.26M17.1M31.43M23.29M16.16M-32.48K-3.74K
Treasury Stock0000000000000000000
Accumulated OCI4.17K-199.2K2.31M3.04M5.66M4.13M2.75M3.82M4.9M2.66M4.17M5.28M5.21M4.43M4.06M2.43M-362.26K-32.48K0
Minority Interest00-1.35M-1.35M-1.35M-1.34M-1.81M-1.19M00039.06K40.54K-1.88K-1.07K0000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Regulatory-driven business model collapse

Asset Base Contraction Signals Decline

As reported in recent financial statements, Ridgetech's total assets have plummeted from $116.9M in 2022Q2 to $61.4M by 2026Q2, reflecting a significant downsizing of the company's operational footprint and a potential loss of market relevance within the Chinese medical distribution sector.

The consistent reduction in total assets suggests that the company is liquidating or failing to replace its core operating base as revenue contracts. This trajectory indicates that the business is shrinking rather than optimizing, which may limit its future capacity to compete for large-scale procurement tenders.

Deleveraging Driven by Operational Necessity

Based on quarterly filings, Ridgetech has aggressively reduced its total debt from a peak of $52.2M in 2022Q2 to just $4.7M in 2026Q2, a shift that appears to be a forced response to shrinking operational scale rather than a strategic capital allocation decision.

While the reduction in debt-to-equity from 2.14 to 0.16 improves the headline leverage profile, it likely reflects a loss of access to credit markets or a deliberate move to minimize interest expenses amidst declining revenue. Investors should monitor whether this low leverage limits the company's ability to finance the working capital required for inventory procurement.

Liquidity Buffer Masks Operational Fragility

According to the latest balance sheet data, Ridgetech maintains a current ratio of 1.82, yet this liquidity position is supported by a shrinking asset base and $13.9M in cash that may be insufficient to cover long-term operating deficits in a high-volume, low-margin environment.

The current ratio improvement appears to be a byproduct of debt repayment and asset liquidation rather than improved cash generation. Given the negative operating margins, this cash buffer may be rapidly consumed, leaving the company with limited flexibility to navigate further regulatory shocks or supply chain disruptions.

Equity Erosion Through Retained Losses

As indicated by historical balance sheet data, Ridgetech's retained earnings have remained deeply negative, reaching -$63.4M in 2026Q2, which highlights a persistent inability to generate sustainable shareholder value despite the company's long-term presence in the medical distribution market.

The persistent deficit in retained earnings suggests that the company has been unable to achieve the economies of scale necessary to offset its fixed cost structure. This ongoing erosion of equity warrants further investigation into whether the company will require future capital injections to remain a going concern.

Asset Quality and Hidden Risks

Based on the provided financial data, the near-total disappearance of net PPE, which fell from $24.8M in 2022Q2 to a negligible $7.1K in 2026Q2, suggests that the company has effectively divested its physical infrastructure, potentially signaling a pivot away from core distribution capabilities.

The collapse in PPE value is a non-obvious risk that implies the company may no longer possess the physical logistics assets required to maintain its regional distribution network. This shift raises questions about the company's long-term operational viability and whether it is transitioning into a hollowed-out entity.

RDGT — Frequently Asked Questions

Quick answers to the most common questions about buying RDGT stock.

What are the total assets of Ridgetech Inc. (RDGT)?

As of 2025, Ridgetech Inc. (RDGT) had total assets of $64.5M including $59.7M in current assets.

How much debt does Ridgetech Inc. (RDGT) have?

Ridgetech Inc. (RDGT) carries total debt of $10.4M, offset by $12.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Ridgetech Inc.?

Ridgetech Inc. (RDGT) has total shareholders' equity (book value) of $29.6M ($120473.10 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Ridgetech Inc.'s current ratio and liquidity?

Ridgetech Inc. (RDGT) reported a current ratio of 1.74x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.